These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 8547210)
1. Hemodynamic and antiischemic effects of intravenous elgodipine, a new dihydropyridine calcium channel blocker, in patients with chronic stable angina. Kuhn A; Carlsson J; Miketic S; Tebbe U Cardiovasc Drugs Ther; 1995 Aug; 9(4):595-600. PubMed ID: 8547210 [TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of intravenous elgodipine in coronary artery disease during rest and exercise, and basic pharmacokinetic parameters. Silke B; de la Motte S; Spiers P; Herity NA; Drake M; Kelly J; Harrison FJ Cardiovasc Drugs Ther; 1996 Nov; 10(5):573-80. PubMed ID: 8950073 [TBL] [Abstract][Full Text] [Related]
3. Anti-ischaemic and haemodynamic effects of elgodipine, a potent new generation calcium antagonist, in chronic stable angina. Acharya DU; Senior R; Basu S; Harrison F; Galiano A; Lahiri A Eur Heart J; 1994 May; 15(5):665-71. PubMed ID: 8056008 [TBL] [Abstract][Full Text] [Related]
4. Potassium channel openers and blockers in coronary artery disease. Comparison to betablockers and calcium antagonists. Mitrovic V; Oehm E; Thormann J; Pitschner H; Hamm C Herz; 2000 Mar; 25(2):130-42. PubMed ID: 10829253 [TBL] [Abstract][Full Text] [Related]
5. Hemodynamic effects of felodipine at rest and during exercise in exertional angina pectoris. Detry JM; De Coster PM; Renkin J Am J Cardiol; 1983 Sep; 52(5):453-7. PubMed ID: 6613867 [TBL] [Abstract][Full Text] [Related]
6. Effects of oral isradipine on left ventricular function at rest and during exercise in patients with stable chronic angina: a double-blind, placebo-controlled crossover study. Delonca J; Kipfer P; Righetti A J Cardiovasc Pharmacol; 1992 Jan; 19(1):126-33. PubMed ID: 1375679 [TBL] [Abstract][Full Text] [Related]
7. Lack of negative inotropic effects of the new calcium antagonist Ro 40-5967 in patients with stable angina pectoris. Portegies MC; Schmitt R; Kraaij CJ; Braat SH; Gassner A; Hagemeijer F; Pozenel H; Prager G; Viersma JW; van der Wall EE J Cardiovasc Pharmacol; 1991 Nov; 18(5):746-51. PubMed ID: 1723772 [TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind comparison of 10 and 20 mg lercanidipine in patients with stable effort angina: effects on myocardial ischemia and heart rate variability. Acanfora D; Trojano L; Gheorghiade M; Picone C; Papa A; Furgi G; Giuliano F; Maestri R; Rengo F Am J Ther; 2002; 9(5):444-53. PubMed ID: 12237738 [TBL] [Abstract][Full Text] [Related]
9. Hemodynamic and antianginal effects during rest and exercise of intravenous isradipine, a new dihydropyridine calcium antagonist. Burger W; Neidel S; Kober G Clin Cardiol; 1989 Jul; 12(7):393-8. PubMed ID: 2525975 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the potassium channel blocker tedisamil with the beta-adrenoceptor blocker esmolol and the calcium antagonist gallopamil in patients with coronary artery disease. Mitrovic V; Oehm E; Thormann J; Pitschner H; Haberbosch W Clin Cardiol; 1998 Jul; 21(7):492-502. PubMed ID: 9669058 [TBL] [Abstract][Full Text] [Related]
11. Effects of the new calcium antagonist efonidipine hydrochloride on resting and exercise hemodynamics in patients with stable effort angina. Saito T; Fujii K; Takizawa T; Toyosaki T; Kuwabara Y; Kobayashi S; Ichikawa H; Karaki A; Yamazaki Y; Iwata J; Yamada K; Tomiya H; Takeda K; Inagaki Y Arzneimittelforschung; 1996 Sep; 46(9):861-7. PubMed ID: 8876934 [TBL] [Abstract][Full Text] [Related]
12. The central and regional cardiovascular responses to intravenous and intracoronary administration of the phenyldihydropyridine elgodipine in anaesthetized pigs. Sassen LM; Soei LK; Koning MM; Verdouw PD Br J Pharmacol; 1990 Feb; 99(2):355-63. PubMed ID: 2328400 [TBL] [Abstract][Full Text] [Related]
13. Hemodynamic, antiischemic, and neurohumoral effects of tedisamil and atenolol in patients with coronary artery disease. Mitrovic V; Miskovic A; Strau M; Thormann J; Pitschner H; Hamm C Cardiovasc Drugs Ther; 2000 Oct; 14(5):511-21. PubMed ID: 11101199 [TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of the calcium channel blocker pranidipine on exercise-induced angina. Nishinaka Y; Yokota M; Watanabe M; Sobue T; Iwase M; Ukai M; Ando A; Nagata K; Saito H Int J Clin Pharmacol Ther; 1994 Oct; 32(10):542-9. PubMed ID: 7834162 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the haemodynamic profiles of elgodipine and nicardipine in the anaesthetized dog. Drieu la Rochelle CD; Grosset A; O'Connor SE Br J Pharmacol; 1994 Jan; 111(1):49-56. PubMed ID: 8012724 [TBL] [Abstract][Full Text] [Related]
16. Effects of a new second generation calcium channel blocker, nilvadipine (FR34235), on exercise-induced hemodynamic changes in stable angina pectoris. Yokota M; Koide M; Miyahara T; Kamihara S; Tsunekawa A; Noda S; Sotobata I J Am Coll Cardiol; 1987 Oct; 10(4):830-6. PubMed ID: 3655150 [TBL] [Abstract][Full Text] [Related]
17. Important differences between short- and long-term hemodynamic effects of amiodarone in patients with chronic ischemic heart disease at rest and during ischemia-induced left ventricular dysfunction. Pfisterer M; Burkart F; Müller-Brand J; Kiowski W J Am Coll Cardiol; 1985 May; 5(5):1205-11. PubMed ID: 3989133 [TBL] [Abstract][Full Text] [Related]
18. Hemodynamic mechanisms of antianginal action of calcium channel blocker nisoldipine in dynamic exercise-induced angina. Yokota M; Miyahara T; Iwase M; Watanabe M; Matsunami T; Kamihara S; Koide M; Saito H; Takeuchi J Circulation; 1990 Jun; 81(6):1887-98. PubMed ID: 2344682 [TBL] [Abstract][Full Text] [Related]
19. Hemodynamic actions of bepridil during treatment of stable angina pectoris. Narahara KA; Shapiro W; Weliky I; Park J Am J Cardiol; 1985 Mar; 55(7):55C-58C. PubMed ID: 3883742 [TBL] [Abstract][Full Text] [Related]
20. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris. Schnellbacher K; Bestehorn HP; Roskamm H J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]